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A commentary on
The scavenger receptor SSc5D physically interacts with bacteria through the SRCR-containing 
N-terminal domain
by Bessa Pereira C, Bocková M, Santos RF, Santos AM, Martins de Araújo M, Oliveira L, et al. Front 
Immunol (2016) 7:416. doi: 10.3389/fimmu.2016.00416
The recently published article by Bessa Pereira et al. reports that the human SSc5D receptor physically 
interacts with some bacterial species (1), thus basically confirming previous available information on 
its mouse homolog (S5D-SRCRB) (2). The interspecies conservation of such a basic innate immune 
function (bacterial binding) has been noticed for other members of the scavenger receptor cysteine-
rich superfamily (SRCR-SF) (e.g., human Spα and its mouse homolog AIM/Api6/CD5L) (3, 4). This 
advocates for its functional physiological relevance in innate defense of body surfaces as it has been 
proposed for the urogenital tract (5).
A substantive part of the work by Bessa Pereira et al. is also devoted to explore putative qualita-
tive and/or quantitative differences on the bacterial-binding properties of SSc5D with other human 
SRCR-SF proteins, namely, CD5, Spα, and CD6 by using conventional protein–bacteria binding 
assays and surface plasmon resonance-based assays. They were chosen based on previously reported 
information showing that Spα (4) and CD6 (6–8) but not CD5 (9) exhibit broad bacterial-binding 
properties. While the authors confirmed the work on Spα and CD5, they were unable to replicate 
that on CD6. Exclusively based on a single experimental evidence, the authors cast doubt on the 
well-documented bacterial-binding properties of CD6 (6–8). These properties were unveiled by 
using a recombinant soluble form of human CD6 (rshCD6) encompassing from D25 to M400 and, 
indistinctly, produced in different mammalian cell expression systems (NSO, HEK293-EBNA, and 
CHO cells). Further confirmation was obtained by demonstrating similar properties displayed by a 
natural soluble CD6 form isolated from human serum, as well as by Jurkat cell transfectants express-
ing a membrane-bound full-length form of CD6 (6). Accordingly, it was later reported that rshCD6 
infusion significantly reduces mouse mortality following septic shock induced by intraperitoneal 
monobacterial infection of Gram-positive (S. aureus) or Gram-negative (A. baumannii) origin (7). 
More recently, new evidence shows that not only rshCD6 but also adenovirally expressed mouse 
sCD6 have protective survival effects on polymicrobial septic shock induced by cecal ligation and 
puncture (8), the gold standard model for experimental sepsis.
The only shCD6 protein assayed by Bessa Pereira et al. was the chimerical HA–sCD6–BirA–His, 
which differed from rshCD6 in several aspects: (1) the CD6 component from HA–sCD6–BirA–His 
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was slightly shorter than that of rshCD6 (D25 to E398 vs D25 
to M400, respectively), (2) in contrast to rshCD6, the chimerical 
HA–sCD6–BirA–His protein included N- and/or C-terminal 
protein tags (e.g., HA, BirA, or His tail), and (3) the chimerical 
HA–sCD6–BirA–His protein was tetrameric whereas rshCD6 
was monomeric under native conditions (our unpublished 
observations). While differences in shCD6 sequence length 
can be considered functionally meaningless in our opinion, the 
introduction of protein tags and/or the formation of tetramerical 
structures could impose important steric limitations preventing 
shCD6 interaction with bacterial surfaces. Indeed, the spatial 
organization of the three consecutive SRCR domains in the CD6 
receptor is non-linear (horseshoe-like shaped) (10), and such a 
topology would explain how monoclonal antibodies against the 
CD6 domain 1 might impede access of CD166/ALCAM—the 
CD6 ligand—to its binding site at the membrane-proximal 
domain (D3) of CD6 (10). The reason by which similar chimeri-
cal versions of the other receptors in study (Spα and SSc5D) do 
still bind to bacteria and do not undergo putative steric hindrance 
issues is uncertain. However, the presence sialylated O-linked 
glycans interspacing their SRCR domains of Spα and SSc5D (but 
not CD6) could impose them to adopt a rigid rod-like shaped 
conformation similar to that previously reported for CD5 (11). 
This would minimize steric problems when tetramerized.
The higher avidity of chimerical protein tetramers compared to 
untagged monomeric proteins could certainly make them advan-
tageous for unraveling low-affinity receptor–ligand interactions. 
However, the physiological meaning of data generated with them 
should always be taken cautiously, especially when the original 
receptor is monomeric and does not contain any similar protein 
tag, as it the case of both the membrane-bound and the soluble-
circulating CD6 forms. Reasonably, Bessa Pereira et al. validated 
the functionality of the chimerical HA–sCD6–BirA–His protein 
by means of flow cytometry analyses showing its specific bind-
ing to CD166/ALCAM-expressing human cell lines, a property 
also shared by the rshCD6 protein used in our studies (6). In our 
opinion, this minimal sine qua non-condition should not be taken 
as an absolute criterion of full shCD6 functionality, particularly 
when the bacterial-binding site/s has/ve not yet been identified 
and there is no evidence for its mapping or close relationship with 
the CD166/ALCAM-binding site.
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